Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects

This paper presents a comprehensive review of the current literature, clinical trials, and products approved for the delivery of antibiotics to the lungs. While there are many literature reports describing potential delivery systems, few of these have translated into marketed products. Key challenge...

Full description

Saved in:
Bibliographic Details
Main Authors: Yahya H. Dallal Bashi, Rachel Mairs, Rand Murtadha, Vicky Kett
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/17/1/111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587693251362816
author Yahya H. Dallal Bashi
Rachel Mairs
Rand Murtadha
Vicky Kett
author_facet Yahya H. Dallal Bashi
Rachel Mairs
Rand Murtadha
Vicky Kett
author_sort Yahya H. Dallal Bashi
collection DOAJ
description This paper presents a comprehensive review of the current literature, clinical trials, and products approved for the delivery of antibiotics to the lungs. While there are many literature reports describing potential delivery systems, few of these have translated into marketed products. Key challenges remaining are the high doses required and, for powder formulations, the ability of the inhaler and powder combination to deliver the dose to the correct portion of the respiratory tract for maximum effect. Side effects, safety concerns, and disappointing clinical trial results remain barriers to regulatory approval. In this review, we describe some possible approaches to address these issues and highlight prospects in this area.
format Article
id doaj-art-1c52a3b6287b480c9dc5c58e44cd8e4f
institution Kabale University
issn 1999-4923
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-1c52a3b6287b480c9dc5c58e44cd8e4f2025-01-24T13:46:00ZengMDPI AGPharmaceutics1999-49232025-01-0117111110.3390/pharmaceutics17010111Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future ProspectsYahya H. Dallal Bashi0Rachel Mairs1Rand Murtadha2Vicky Kett3School of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UKSchool of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UKSchool of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UKSchool of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UKThis paper presents a comprehensive review of the current literature, clinical trials, and products approved for the delivery of antibiotics to the lungs. While there are many literature reports describing potential delivery systems, few of these have translated into marketed products. Key challenges remaining are the high doses required and, for powder formulations, the ability of the inhaler and powder combination to deliver the dose to the correct portion of the respiratory tract for maximum effect. Side effects, safety concerns, and disappointing clinical trial results remain barriers to regulatory approval. In this review, we describe some possible approaches to address these issues and highlight prospects in this area.https://www.mdpi.com/1999-4923/17/1/111cystic fibrosisbronchiectasisinhalationDPInebulizertobramycin
spellingShingle Yahya H. Dallal Bashi
Rachel Mairs
Rand Murtadha
Vicky Kett
Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
Pharmaceutics
cystic fibrosis
bronchiectasis
inhalation
DPI
nebulizer
tobramycin
title Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
title_full Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
title_fullStr Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
title_full_unstemmed Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
title_short Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
title_sort pulmonary delivery of antibiotics to the lungs current state and future prospects
topic cystic fibrosis
bronchiectasis
inhalation
DPI
nebulizer
tobramycin
url https://www.mdpi.com/1999-4923/17/1/111
work_keys_str_mv AT yahyahdallalbashi pulmonarydeliveryofantibioticstothelungscurrentstateandfutureprospects
AT rachelmairs pulmonarydeliveryofantibioticstothelungscurrentstateandfutureprospects
AT randmurtadha pulmonarydeliveryofantibioticstothelungscurrentstateandfutureprospects
AT vickykett pulmonarydeliveryofantibioticstothelungscurrentstateandfutureprospects